Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States

por Ross, Lisa L., Shortino, Denise, Shaefer, Mark S.
Publicado 2018

HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57...

por Small, Catherine Butkus, Margolis, David A., Shaefer, Mark S., Ross, Lisa L.
Publicado 2017

Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudi...

por Robertson, Kevin, Maruff, Paul, Ross, Lisa L., Wohl, David, Small, Catherine B, Edelstein, Howard, Shaefer, Mark S.
Publicado 2018

Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Updated Meta-analysis of Data from Clinical Trials

por Nan, Cassandra, Shaefer, Mark S, Urbaityte, Rimgaile, Oyee, James, Hopking, Judy, Ragone, Leigh, McCoig, Cynthia, Vannappagari, Vani
Publicado 2017

A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice...

por Kumar, Princy N, Salvato, Patricia, LaMarca, Anthony, DeJesus, Edwin, Patel, Parul, McClernon, Daniel, Florance, Allison, Shaefer, Mark S
Publicado 2009

Effect of Sorbitol on the Pharmacokinetic Profile of Lamivudine Oral Solution in Adults: An Open‐Label, Randomized Study

por Adkison, Kimberly, Wolstenholme, Allen, Lou, Yu, Zhang, Zhiping, Eld, Amy, Perger, Teodora, Vangerow, Harald, Hayward, Katy, Shaefer, Mark, McCoig, Cynthia
Publicado 2017

Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials

por Nan, Cassandra, Shaefer, Mark, Urbaityte, Rimgaile, Oyee, James, Hopking, Judy, Ragone, Leigh, Perger, Teodora, Win, Beta, Vangerow, Harald, McCoig, Cynthia, Vannappagari, Vani
Publicado 2018

HLA-B*57:01 screening and hypersensitivity reaction to abacavir between 1999 and 2016 in the OPERA(®) observational database: a cohort study

por Mounzer, Karam, Hsu, Ricky, Fusco, Jennifer S., Brunet, Laurence, Henegar, Cassidy E., Vannappagari, Vani, Stainsby, Chris M., Shaefer, Mark S., Ragone, Leigh, Fusco, Gregory P.
Publicado 2019

Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks

por Squires, Kathleen E, Young, Benjamin, Santiago, Lizette, Dretler, Robin H, Walmsley, Sharon L, Zhao, Henry H, Pakes, Gary E, Ross, Lisa L, Shaefer, Mark S
Publicado 2017

Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial

por Wohl, David A., Bhatti, Laveeza, Small, Catherine B., Edelstein, Howard, Zhao, Henry H., Margolis, David A., DeJesus, Edwin, Weinberg, Winkler G., Ross, Lisa L., Shaefer, Mark S.
Publicado 2014

HIV-1 Transmission Patterns in Antiretroviral Therapy-Naïve, HIV-Infected North Americans Based on Phylogenetic Analysis by Population Level and Ultra-Deep DNA Sequencing

por Ross, Lisa L., Horton, Joseph, Hasan, Samiul, Brown, James R., Murphy, Daniel, DeJesus, Edwin, Potter, Martin, LaMarca, Anthony, Melendez-Rivera, Ivan, Ward, Douglas, Uy, Jonathon, Shaefer, Mark S.
Publicado 2014

Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure

por Stainsby, Chris M., Perger, Teodora M., Vannappagari, Vani, Mounzer, Karam C., Hsu, Ricky K., Henegar, Cassidy E., Oyee, James, Urbaityte, Rimgaile, Lane, Charlotte E., Carter, Lindsay M., Pakes, Gary E., Shaefer, Mark S.
Publicado 2018

Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M)

por Chounta, Vasiliki, Overton, Edgar T., Mills, Anthony, Swindells, Susan, Benn, Paul D., Vanveggel, Simon, van Solingen-Ristea, Rodica, Wang, Yuanyuan, Hudson, Krischan J., Shaefer, Mark S., Margolis, David A., Smith, Kimberly Y., Spreen, William R.
Publicado 2021

884. Patient Adherence to Long-Acting Injectable Cabotegravir + Rilpivirine Through 48 Weeks of Maintenance Therapy in the Phase 3 ATLAS and FLAIR Studies

por Teichner, Paula, Cutrell, Amy, D’Amico, Ronald, Dorey, David, Griffith, Sandy, Harrington, Conn M, Huang, Jenny, Hudson, Krischan J, Margolis, David, Mrus, Joseph, Polli, Joseph, Spreen, William, Williams, Peter, Van Solingen-Ristea, Rodica, Shaefer, Mark S
Publicado 2019

2497. Women’s Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preference...

por Mantsios, Andrea R, Murray, Miranda, Karver, Tahilin Sanchez, Davis, Wendy, Margolis, David, Kumar, Princy, Swindells, Susan, Bredeek, Fritz, Deltoro, Miguel García, García, Rafael Rubio, Antela, Antonio, Garris, Cindy, Shaefer, Mark S, Gomis, Santiago Cenoz, Bernaldez, Miguel Pascual, Kerrigan, Deanna
Publicado 2019

Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks

por Murray, Miranda, Antela, Antonio, Mills, Anthony, Huang, Jenny, Jäger, Hans, Bernal, Enrique, Lombaard, Johan, Katner, Harold, Walmsley, Sharon, Khuong-Josses, Marie-Aude, Hudson, Krischan, Dorey, David, Griffith, Sandy, Spreen, William, Vanveggel, Simon, Shaefer, Mark, Margolis, David, Chounta, Vasiliki
Publicado 2020

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretro...

por Ross, Lisa L., Walker, A. Sarah, Lou, Yu, Tenorio, Allan R., Gibb, Diana M., Double, Julia, Gilks, Charles, McCoig, Cynthia C., Munderi, Paula, Musoro, Godfrey, Kityo, Cissy M., Grosskurth, Heiner, Hakim, James, Mugyenyi, Peter N., Cutrell, Amy, Perger, Teodora, Shaefer, Mark S.
Publicado 2019